Updates on Giant Cell Arteritis: Pathogenesis, Diagnosis and Treatment, volume II

21.9K

views

59

authors

11

articles

Editors

2

Andreas P Diamantopoulos

Akershus University Hospital

Stavros Chrysidis

Sydvestjysk Sygehus

Impact

About

Building on the success of Updates on Giant Cell Arteritis: Pathogenesis, Diagnosis and Treatment, we are pleased to relaunch Volume II of this Research Topic.

Giant cell arteritis (GCA) or 'temporal arteritis’ symptoms include a new headache around the temples as well as the front, top and back of the skull. Other common symptoms include fatigue, weight-loss, an unexplained fever and can include pains in the jaw, throat and tongue, double vision and eventually blindness. Blindness resulting from GCA can occur suddenly however early treatment can prevent this.

While there is no simple diagnosis for GCA, ultrasound has recently emerged as a leading diagnostic resource for early detection of this severe condition. High dose corticosteroid treatment is still the mainstream of treatment but IL6 inhibition has provided new opportunities to these patients and has also challenged classic treatment algorithms.

This Research Topic aims to provide an update on the pathogenesis, diagnosis and treatment of GCA in order to improve patient outcomes.

Building on the success of Updates on Giant Cell Arteritis: Pathogenesis, Diagnosis and Treatment, we are pleased to relaunch Volume II of this Research Topic.

Giant cell arteritis (GCA) or 'temporal arteritis’ symptoms include a new headache around the temples as well as the front, top and back of the skull. Other common symptoms include fatigue, weight-loss, an unexplained fever and can include pains in the jaw, throat and tongue, double vision and eventually blindness. Blindness resulting from GCA can occur suddenly however early treatment can prevent this.

While there is no simple diagnosis for GCA, ultrasound has recently emerged as a leading diagnostic resource for early detection of this severe condition. High dose corticosteroid treatment is still the mainstream of treatment but IL6 inhibition has provided new opportunities to these patients and has also challenged classic treatment algorithms.

This Research Topic aims to provide an update on the pathogenesis, diagnosis and treatment of GCA in order to improve patient outcomes.

Download ebook

Share

Editors

Andreas P Diamantopoulos

Akershus University Hospital

Stavros Chrysidis

Sydvestjysk Sygehus

Impact

21,927 Total views

16,354 Article views

4,689 Article downloads

884 Topic views

Published In

Journal Thumbnail

Frontiers in Medicine

About Frontiers Research Topics

With their unique mixes of varied contributions from Original Research to Review Articles, Research Topics unify the most influential researchers, the latest key findings and historical advances in a hot research area! Find out more on how to host your own Frontiers Research Topic or contribute to one as an author.

Suggest a topic